造血干细胞移植后并发出血性膀胱炎患者护理评估和干预的最佳证据总结

doi:10.3761/j.issn.0254-1769.2023.15.017

摘要/Abstract

摘要：

目的检索造血干细胞移植后并发出血性膀胱炎患者护理评估和干预的相关证据，并对最佳证据进行总结，为临床实践提供参考。方法应用循证方法，遵循“6S”证据金字塔模型检索相关文献，检索时限为建库至2022年5月30日。采用乔安娜布里格斯研究所循证卫生保健中心的文献质量评价标准和证据分级系统，对纳入文献进行质量评价及证据级别评定。结果共纳入14篇文献，其中临床决策1篇、指南2篇、最佳实践1篇、专家共识3篇、系统评价7篇。总结的最佳证据包括危险因素评估、辅助检查评估、症状体征评估、生活方式指导、药物干预、综合干预6个方面，共23条。结论该研究总结了造血干细胞移植后并发出血性膀胱炎患者护理评估和干预的最佳证据，建议护理人员在应用证据时，充分考虑患者的实际情况，进行正确评估和有效干预。

关键词: 造血干细胞移植, 出血性膀胱炎, 护理评估, 循证护理学

Abstract:

Objective To search，evaluate and summarize the best evidence of assessment and nursing for hemorrhagic cystitis patients undergoing hematopoietic stem cell transplantation，so as to provide a reference for clinical practice. Methods Evidence-based method was used to search the relevant literature according to the "6S" evidence pyramid model. The time limit for the literature search is from the inception of databases until May 30，2022. Results A total of 14 pieces of literature were included，including 1 clinical decisional support，2 guidelines，1 best practice report，3 consensuses，7 systematic reviews. Totally 23 pieces of evidence were summarized with 6 topics，including assessment of risk factors，auxiliary examination assessment，symptom assessment，lifestyle guidance，medication-based prevention，and comprehensive intervention. Conclusion This study summarizes the best available evidence for the assessment and nursing for hemorrhagic cystitis patients undergoing hematopoietic stem cell transplantation. It is recommended that health care providers should fully consider the actual situation of patients，in order to correct assessment and effective intervention.

Key words: Hematopoietic Stem Cell Transplantation, Hemorrhagic Cystitis, Nursing Assessment, Evidence-Based Nursing

谢彩琴, 曾洁, 郑海燕, 吴琳珊, 包涵, 徐奇, 赵悦秋, 姜秋萍, 朱岩. 造血干细胞移植后并发出血性膀胱炎患者护理评估和干预的最佳证据总结[J]. 中华护理杂志, 2023, 58(15): 1892-1898.

XIE Caiqin, ZENG Jie, ZHENG Haiyan, WU Linshan, BAO Han, XU Qi, ZHAO Yueqiu, JIANG Qiuping, ZHU Yan. Evidence summary of assessment and nursing for hemorrhagic cystitis patients undergoing hematopoietic stem cell transplantation[J]. Chinese Journal of Nursing, 2023, 58(15): 1892-1898.

图/表 3

图1 文献检索及筛选流程

Figure 1 Flow chart of literature screening

表1 纳入文献的一般特征（n=14）

Table 1 Characteristics of included studies（n=14）

表2 造血干细胞移植后并发出血性膀胱炎患者护理评估和干预的最佳证据总结

Table 2 Best evidence of assessment and nursing in hemorrhagic cystitis patients undergoing hematopoietic stem cell transplantation

参考文献 30

[1]	郦杭婷, 吴筱莲, 王丽娜, 等. 异基因造血干细胞移植供者症状评估量表的编制和信效度检验[J]. 中华护理杂志, 2022, 57(13):1611-1618. DOI URL
	Li HT, Wu XL, Wang LN, et al. Construction and preliminary application of Symptom Assessment Scale for Donors of Allogeneic-Hematopoietic Stem Cell Transplantation[J]. Chin J Nurs, 2022, 57(13):1611-1618. DOI URL
[2]	孙春红, 王晓宁, 罗敏娜, 等. 异基因造血干细胞移植后并发出血性膀胱炎的危险因素分析[J]. 中国实验血液学杂志, 2021, 29(2):610-614.
	Sun CH, Wang XN, Luo MN, et al. Analysis of the risk factors for hemorrhagic cystitis after hematopoietic stem cell trans-plantation[J]. J Exp Hematol, 2021, 29(2):610-614.
[3]	Hassan Z. Management of refractory hemorrhagic cystitis follow-ing hematopoietic stem cell transplantation in children[J]. Pediatr Transplant, 2011, 15(4):348-361. DOI URL
[4]	Lunde LE, Dasaraju S, Cao Q, et al. Hemorrhagic cystitis after allogeneic hematopoietic cell transplantation:risk factors,graft source and survival[J]. Bone Marrow Transplant, 2015, 50(11):1432-1437. DOI
[5]	Shen B, Ma YS, Zhang HX, et al. Risk factors associated with hemorrhagic cystitis after allogeneic hematopoietic stem cell transplantation[J]. Blood Sci, 2022, 4(2):83-88. DOI URL
[6]	中华医学会血液学分会. 造血干细胞移植后出血并发症管理中国专家共识(2021年版)[J]. 中华血液学杂志, 2021, 42(4):276-280.
	Chinese Society of Hematology,Chinese Medical Association. Chinese expert consensus on the management of hemorrhagic complications after hematopoietic stem cell transplantation(2021)[J]. Chin J Hematol, 2021, 42(4):276-280.
[7]	Hoffmann-Eβer W, Siering U, Neugebauer EAM, et al. Guideline appraisal with AGREE Ⅱ:online survey of the potential influence of AGREE Ⅱ items on overall assessment of guideline quality and recommendation for use[J]. BMC Health Serv Res, 2018, 18(1):143. DOI PMID
[8]	胡雁, 郝玉芳. 循证护理学[M]. 2版. 北京: 人民卫生出版社, 2018,77-78.
	Hu Y, Hao YF. Evidence-based nursing[M]. 2nd ed. Beijing: People’s Medical Publishing House, 2018,77-78.
[9]	Pieper D, Buechter RB, Li L, et al. Systematic review found AMSTAR,but not Revised-AMSTAR,to have good measure-ment properties[J]. J Clin Epidemiol, 2015, 68(5):574-583. DOI PMID
[10]	庞永丽, 方蘅英, 罗媛容, 等. 肝硬化患者营养评估与管理的最佳证据总结[J]. 中华护理杂志, 2020, 55(9):1420-1425. DOI URL
	Pang YL, Fang HY, Luo YR, et al. Best evidence summary of nutritional assessment and management in patients with liver cirrhosis[J]. Chin J Nurs, 2020, 55(9):1420-1425. DOI URL
[11]	Cesaro S, Dalianis T, Hanssen Rinaldo C, et al. ECIL guide-lines for the prevention,diagnosis and treatment of BK polyo-mavirus-associated haemorrhagic cystitis in haematopoietic stem cell transplant recipients[J]. J Antimicrob Chemother, 2018, 73(1):12-21.
[12]	潘小容, 莫霖, 黄先巧, 等. 造血干细胞移植并发出血性膀胱炎危险因素的Meta分析[J]. 护理学杂志, 2018, 33(19):89-94.
	Pan XR, Mo L, Huang XQ, et al. Risk factors of hemorrhagic cystitis after hematopoietic stem cell transplantation:a meta-analysis[J]. J Nurs Sci, 2018, 33(19):89-94.
[13]	Linder BJ, Chao NJ, Gounder MM, et al. Chemotherapy and ra-diation-related hemorrhagic cystitis in cancer patients[EB/OL].(2021-09-16)[2022-06-02]. https://www.uptodate.com/con-tents/chemotherapy-and-radiation-related-hemorrhagic-cystitis-in-cancer-patients.
[14]	Thompson A, Adamson A, Bahl A, et al. Guidelines for the diagnosis,prevention and management of chemical- and radia-tion-induced cystitis[J]. J Clin Urol, 2014, 7(1):25-35.
[15]	Aldiwani M, Tharakan T, Al-Hassani A, et al. BK virus asso-ciated haemorrhagic cystitis. A systematic review of current prevention and treatment strategies[J]. Int J Surg, 2019, 63:34-42. DOI PMID
[16]	王春青, 胡雁. JBI证据预分级及证据推荐级别系统(2014版)[J]. 护士进修杂志, 2015, 30(11):964-967.
	Wang CQ, Hu Y. JBI evidence pre-classification and evidence rank system(2014 edition)[J]. J Nurses Train, 2015, 30(11):964-967.
[17]	Hensley ML, Hagerty KL, Kewalramani T, et al. American So-ciety of Clinical Oncology 2008 clinical practice guideline update:use of chemotherapy and radiation therapy protectants[J]. J Clin Oncol, 2009, 27(1):127-145. DOI PMID
[18]	Goucher G, Saad F, Lukka H, et al. Canadian Urological Asso-ciation best practice report:diagnosis and management of radiation-induced hemorrhagic cystitis[J]. J De L’association Des Urol Du Can, 2019, 13(2):15-23.
[19]	Dalianis T, Eriksson BM, Felldin M, et al. Management of BK-virus infection:Swedish recommendations[J]. Infect Dis (Lond), 2019, 51(7):479-484.
[20]	Visintini C, Venturini M, Palese A. Haemorrhagic cystitis,pre-ventive and treatment interventions in patients undergoing haematopoietic stem cell transplantation:a scoping review[J]. Eur J Oncol Nurs, 2019, 42:50-62. DOI PMID
[21]	Cardinal J, Slade A, McFarland M, et al. Scoping review and meta-analysis of hyperbaric oxygen therapy for radiation-induced hemorrhagic cystitis[J]. Curr Urol Rep, 2018, 19(6):38. DOI PMID
[22]	Schneidewind L, Neumann T, Schmidt CA, et al. Comparison of intravenous or intravesical cidofovir in the treatment of BK polyomavirus-associated hemorrhagic cystitis following adult allogeneic stem cell transplantation:a systematic review[J]. Transpl Infect Dis, 2018, 20(4):e12914. DOI URL
[23]	Pitto CM, García-Perdomo HA. Interventions to treat hemorr-hagic cystitis:a systematic review and meta-analysis[J]. Sup-port Care Cancer, 2017, 25(7):2043-2046.
[24]	Payne H, Adamson A, Bahl A, et al. Chemical- and radiation-induced haemorrhagic cystitis:current treatments and chal-lenges[J]. BJU Int, 2013, 112(7):885-897.
[25]	Galli E, Sorà F, Di Gianfrancesco L, et al. Hemorrhagic cysti-tis in allogeneic stem cell transplantation:a role for age and prostatic hyperplasia[J]. Support Care Cancer, 2022, 30(6):4953-4959. DOI
[26]	Laskin BL, Denburg M, Furth S, et al. BK viremia precedes hemorrhagic cystitis in children undergoing allogeneic hematopoietic stem cell transplantation[J]. Biol Blood Marrow Transplant, 2013, 19(8):1175-1182. DOI URL
[27]	U.S. Department of Health and Human Services. Common terminology criteria for adverse events(CTCAE) version 5.0[EB/OL].(2017-11-27)[2022-06-02]. https://ctep.cancer.gov/protocoldevelopment/electronic_applications/docs/CTCAE_v5_Quick_Reference_8.5x11.pdf.
[28]	Mac S, Ngo D, Yang DY, et al. Use of high-dose mesna and hyperhydration leads to lower incidence of hemorrhagic cystitis after posttransplant cyclophosphamide-based allogeneic transplantation[J]. Bone Marrow Transplant, 2021, 56(10):2464-2470. DOI
[29]	Almalag HM, Alasmari SS, Alrayes MH, et al. Incidence of he-morrhagic cystitis after cyclophosphamide therapy with or without mesna:a cohort study and comprehensive literature review[J]. J Oncol Pharm Pract, 2021, 27(2):340-349. DOI URL
[30]	解丹, 郑瑾, 苏兰若. 两种膀胱冲洗液温度对经尿道前列腺电切除术后出血和膀胱痉挛的影响[J]. 中华护理杂志, 2011, 46(4):334-336.
	Xie D, Zheng J, Su LR. Effects of different irrigation fluid temperature on postoperative bleeding and cystospasm in patients after transurethral resection of the prostate[J]. Chin J Nurs, 2011, 46(4):334-336.